Dimensional Fund Advisors
NBIX icon

Dimensional Fund Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$86M Buy
684,439
+68,803
+11% +$8.65M 0.02% 1139
2025
Q1
$68.1M Buy
615,636
+65,479
+12% +$7.24M 0.02% 1270
2024
Q4
$75.1M Buy
550,157
+26,525
+5% +$3.62M 0.02% 1258
2024
Q3
$60.3M Buy
523,632
+50,703
+11% +$5.84M 0.01% 1396
2024
Q2
$65.1M Buy
472,929
+147,907
+46% +$20.4M 0.02% 1282
2024
Q1
$44.8M Sell
325,022
-11,514
-3% -$1.59M 0.01% 1532
2023
Q4
$44.3M Buy
336,536
+5,907
+2% +$778K 0.01% 1529
2023
Q3
$37.2M Sell
330,629
-5,535
-2% -$623K 0.01% 1535
2023
Q2
$31.7M Buy
336,164
+15,682
+5% +$1.48M 0.01% 1678
2023
Q1
$32.4M Sell
320,482
-23,028
-7% -$2.33M 0.01% 1641
2022
Q4
$41K Sell
343,510
-14,029
-4% -$1.68K 0.01% 1439
2022
Q3
$38M Buy
357,539
+2,474
+0.7% +$263K 0.01% 1435
2022
Q2
$34.6M Sell
355,065
-62,539
-15% -$6.1M 0.01% 1560
2022
Q1
$39.1M Buy
417,604
+117,422
+39% +$11M 0.01% 1586
2021
Q4
$25.6M Buy
300,182
+12,225
+4% +$1.04M 0.01% 1858
2021
Q3
$27.6M Buy
287,957
+16,925
+6% +$1.62M 0.01% 1831
2021
Q2
$26.4M Buy
271,032
+14,090
+5% +$1.37M 0.01% 1916
2021
Q1
$25M Buy
256,942
+2,761
+1% +$268K 0.01% 1929
2020
Q4
$24.4M Buy
254,181
+11,612
+5% +$1.11M 0.01% 1879
2020
Q3
$23.3M Buy
242,569
+65,787
+37% +$6.33M 0.01% 1761
2020
Q2
$21.6M Buy
176,782
+12,752
+8% +$1.56M 0.01% 1832
2020
Q1
$14.2M Sell
164,030
-11,848
-7% -$1.03M 0.01% 1937
2019
Q4
$18.9M Sell
175,878
-4,315
-2% -$464K 0.01% 2073
2019
Q3
$16.2M Sell
180,193
-1,375
-0.8% -$124K 0.01% 2122
2019
Q2
$15.3M Buy
181,568
+10,257
+6% +$866K 0.01% 2203
2019
Q1
$15.1M Sell
171,311
-1,946
-1% -$171K 0.01% 2209
2018
Q4
$12.4M Buy
173,257
+6,149
+4% +$439K 0.01% 2235
2018
Q3
$20.5M Sell
167,108
-19,904
-11% -$2.45M 0.01% 2100
2018
Q2
$18.4M Sell
187,012
-5,252
-3% -$516K 0.01% 2143
2018
Q1
$15.9M Buy
192,264
+270
+0.1% +$22.4K 0.01% 2175
2017
Q4
$14.9M Buy
191,994
+10,243
+6% +$795K 0.01% 2207
2017
Q3
$11.1M Buy
181,751
+5,554
+3% +$340K ﹤0.01% 2333
2017
Q2
$8.11M Buy
176,197
+10,782
+7% +$496K ﹤0.01% 2440
2017
Q1
$7.16M Sell
165,415
-538
-0.3% -$23.3K ﹤0.01% 2452
2016
Q4
$6.42M Buy
165,953
+4,428
+3% +$171K ﹤0.01% 2477
2016
Q3
$8.18M Buy
161,525
+18,093
+13% +$916K ﹤0.01% 2328
2016
Q2
$6.52M Buy
143,432
+10,901
+8% +$495K ﹤0.01% 2402
2016
Q1
$5.24M Sell
132,531
-1,772
-1% -$70K ﹤0.01% 2480
2015
Q4
$7.6M Buy
134,303
+9,793
+8% +$554K ﹤0.01% 2340
2015
Q3
$4.95M Buy
124,510
+11,938
+11% +$475K ﹤0.01% 2523
2015
Q2
$5.38M Buy
112,572
+48,472
+76% +$2.31M ﹤0.01% 2560
2015
Q1
$2.55M Buy
+64,100
New +$2.55M ﹤0.01% 2766
2013
Q3
Sell
-34,877
Closed -$467K 3582
2013
Q2
$467K Buy
+34,877
New +$467K ﹤0.01% 3194